Seeing Is Believing
Currently, out of the existing stock ratings of Madhu Kumar - 142 which are a Buy (66.98%), 49 which are a Hold (23.11%), 21 which are a Sell (9.91%)
Analyst Madhu Kumar works at GOLDMAN SACHS and is covering the Healthcare sector with 375 price targets and ratings displayed on 44 stocks. Previously, Madhu Kumar worked at BAIRD, B. RILEY, CHARDAN CAPITAL.
Madhu Kumar's average stock forecast success ratio is 55.45% with an average time for price targets to be met of 173.21 days.
Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 20-Nov-2023.
Analyst best performing recommendations are on CERE (CEREVEL THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS) at 11/25/2019. The price target of $70 was fulfilled within 4 days with a profit of $13.01 (22.83%) receiving and performance score of 57.07.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$3.97 (195.57%)
6
2 months 24 days ago
0/8 (0%)
$3.75 (150.13%)
Buy
4 months 2 days ago
0/4 (0%)
$2.4 (80.25%)
Buy
6
$3.97 (195.57%)
6
5 months ago
0/3 (0%)
$4.35 (169.15%)
Hold
5
$2.94 (142.72%)
1 years 10 months 4 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
10
2 years 5 months 8 days ago
0/2 (0%)
$6.88 (220.99%)
Which stock is Madhu Kumar is most bullish on?
Which stock is Madhu Kumar is most reserved on?
What Year was the first public recommendation made by Madhu Kumar?